Date: November 3, 2026
Board Meeting Outcomes
- The Audit Committee reviewed and confirmed no deviation or variation in QIP fund utilization at its meeting held on November 3, 2026.
- The statement was filed pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular dated November 11, 2024.
Financial Results (Fund Utilization)
QIP Details:
- Date of fund raising: July 28, 2026 (date of allotment)
- Amount raised: ₹1613.97 crore (gross); net proceeds ₹1572.62 crore
- Monitoring agency: CARE Ratings Limited
- Quarter covered: September 30, 2026
Fund Utilization as per Original Objects:
| Object | Original Allocation (₹ Crore) | Funds Utilized (₹ Crore) |
| Repayment/pre-payment of certain outstanding borrowings availed by Company and Promoter Group Entities | 340.00 | 340.00 |
| Funding incremental working capital requirements | 750.00 | 489.08 |
| Funding capital expenditure including expansion and development of manufacturing facility | 205.18 | 33.17 |
| General Corporate Purposes | 277.43 | 198.55 |
| Issue expenses | 41.35 | 36.98 |
| Total | 1613.97 | 1097.78 |
KMP / Board / Auditor Changes
- Jayesh Ravjibhai Patel, Company Secretary (ICSI Mem.No: A14898) signed the disclosure
- Kundip Thakker, Chief Financial Officer, certified the statement
Other Operational / Legal / Strategic Disclosures
- No deviation or variation in use of QIP funds reported for the quarter
- No modified objects or allocations from the original QIP terms
- No comments from Audit Committee or auditors regarding deviations
- The disclosure has been uploaded on the company's website at www.dicabs.com